Peter Scheurich

Oliver Sawodny, Eric Bullinger, Steffen Waldherr, 2006, 2006 IEEE Conference on Computer Aided Control System Design, 2006 IEEE International Conference on Control Applications, 2006 IEEE International Symposium on Intelligent Control.

Dual function of cysteine rich domain (CRD) 1 of TNF receptor type 1: conformational stabilization of CRD2 and control of receptor responsiveness.

Andrea Zappe, Peter Scheurich, P. Scheurich, 2010, Cellular signalling.

Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2.

Peter Scheurich, P. Scheurich, A. Aird, 2010, Cellular signalling.

Response to bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores.

Eric Bullinger, Frank Allgöwer, Steffen Waldherr, 2007, Biophysical journal.

p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells

Peter Scheurich, Frank Henkler, P. Scheurich, 2001, Oncogene.

Visualization methods and support vector machines as tools for determining markers in models of heterogeneous populations: Proapoptotic signaling as a case study

Daniel Weiskopf, Jan Hasenauer, Julian Heinrich, 2011 .

The Human Tumor Necrosis Factor (TNF) Receptor-associated Factor 1 Gene (TRAF1) Is Up-regulated by Cytokines of the TNF Ligand Family and Modulates TNF-induced Activation of NF-κB and c-Jun N-terminal Kinase*

Peter Scheurich, P. Scheurich, R. Schmid, 1999, The Journal of Biological Chemistry.

NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling

Peter Scheurich, Sebastian Kreuz, P. Scheurich, 2001, Molecular and Cellular Biology.

Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF‐R1 activation by endogenous membrane‐anchored TNF

Peter Scheurich, A. Strasser, P. Scheurich, 1999, The EMBO journal.

Analysis of heterogeneous cell populations: A density-based modeling and identification framework

Frank Allgöwer, Nicole Radde, Jan Hasenauer, 2011 .

Mathematical modelling of TNF- induced anti-apoptotic signalling pathways in mammalian cells based on dynamic and quantitative experiments

Eric Bullinger, Monica Schliemann, Peter Scheurich, 2007 .

Reverse Signaling Through Transmembrane TNF Confers Resistance to Lipopolysaccharide in Human Monocytes and Macrophages1

Walter Kolch, Peter Scheurich, Silvia Kirchner, 2000, The Journal of Immunology.

Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system.

Walter Kolch, Peter Scheurich, W. Kolch, 2004, Cytokine & growth factor reviews.

NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP

Peter Scheurich, Jost-Julian Rumpf, Sebastian Kreuz, 2004, The Journal of cell biology.

TNFR1‐induced activation of the classical NF‐κB pathway

Peter Scheurich, P. Scheurich, H. Wajant, 2011, The FEBS journal.

MATHEMATICAL MODELLING OF TNF-α INDUCED APOPTOTIC AND ANTI-APOPTOTIC SIGNALLING PATHWAYS IN MAMMALIAN CELLS BASED ON DYNAMIC AND QUANTITATIVE EXPERIMENTS

Eric Bullinger, Monica Schliemann, Peter Scheurich, 2007 .

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

George Kollias, Peter Scheurich, Eleni Douni, 1995, Cell.

Control of Receptor-induced Signaling Complex Formation by the Kinetics of Ligand/Receptor Interaction*

Peter Scheurich, P. Scheurich, G. Zimmermann, 2002, The Journal of Biological Chemistry.

The Experimental Side of Parameter Estimation

Thierry Bastogne, Eric Bullinger, Rolf Findeisen, 2016 .

Antagonists of TNF action: clinical experience and new developments

Peter Scheurich, Klaus Pfizenmaier, P. Scheurich, 2009, Expert opinion on drug discovery.

Tumor necrosis factor (TNF)-functionalized nanostructured particles for the stimulation of membrane TNF-specific cell responses.

Peter Scheurich, Herwig Brunner, Klaus Pfizenmaier, 2005, Bioconjugate chemistry.